Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvic Acid | 6 | 2022 | 195 | 1.400 |
Why?
|
| Magnetic Resonance Spectroscopy | 6 | 2022 | 3765 | 0.870 |
Why?
|
| Models, Chemical | 2 | 2008 | 614 | 0.520 |
Why?
|
| Alanine | 2 | 2022 | 606 | 0.470 |
Why?
|
| Gene Deletion | 1 | 2021 | 2668 | 0.440 |
Why?
|
| Lactic Acid | 2 | 2022 | 1134 | 0.390 |
Why?
|
| tert-Butyl Alcohol | 1 | 2011 | 3 | 0.390 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1229 | 0.350 |
Why?
|
| Algorithms | 12 | 2016 | 13981 | 0.330 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2015 | 1489 | 0.320 |
Why?
|
| Image Enhancement | 8 | 2015 | 2881 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2022 | 36290 | 0.300 |
Why?
|
| Hydrogen | 1 | 2008 | 171 | 0.290 |
Why?
|
| Carbon Isotopes | 2 | 2015 | 459 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2015 | 3340 | 0.190 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2014 | 412 | 0.190 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2021 | 80 | 0.190 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13262 | 0.180 |
Why?
|
| Brain Mapping | 2 | 2016 | 6568 | 0.180 |
Why?
|
| Contrast Media | 3 | 2015 | 5305 | 0.170 |
Why?
|
| Symporters | 1 | 2021 | 361 | 0.150 |
Why?
|
| Protons | 1 | 2022 | 1114 | 0.140 |
Why?
|
| Thiophenes | 1 | 2021 | 587 | 0.140 |
Why?
|
| Spin Labels | 2 | 2008 | 336 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2016 | 8950 | 0.140 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2016 | 51 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 4319 | 0.130 |
Why?
|
| Pyridones | 1 | 2021 | 792 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1152 | 0.130 |
Why?
|
| Mice, Nude | 3 | 2022 | 3607 | 0.130 |
Why?
|
| BRCA1 Protein | 1 | 2021 | 1147 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 21025 | 0.120 |
Why?
|
| Electromagnetic Fields | 2 | 2008 | 296 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 2007 | 0.110 |
Why?
|
| Phantoms, Imaging | 7 | 2022 | 2512 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 1423 | 0.100 |
Why?
|
| Lactates | 2 | 2022 | 404 | 0.100 |
Why?
|
| Elements | 1 | 2010 | 21 | 0.090 |
Why?
|
| Transducers | 2 | 2009 | 240 | 0.090 |
Why?
|
| Computer Simulation | 5 | 2016 | 6218 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2299 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2011 | 247 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2006 | 4048 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 1431 | 0.080 |
Why?
|
| Glycolysis | 3 | 2022 | 828 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2015 | 818 | 0.080 |
Why?
|
| Rats | 4 | 2022 | 23711 | 0.080 |
Why?
|
| Animals | 11 | 2022 | 167963 | 0.080 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 16939 | 0.080 |
Why?
|
| Artifacts | 2 | 2008 | 1898 | 0.080 |
Why?
|
| Phase Transition | 1 | 2008 | 71 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 14660 | 0.070 |
Why?
|
| Mice | 7 | 2022 | 81208 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2021 | 2758 | 0.070 |
Why?
|
| Solutions | 1 | 2008 | 419 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 662 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2011 | 1850 | 0.070 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 302 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2864 | 0.070 |
Why?
|
| Gadolinium | 1 | 2011 | 959 | 0.070 |
Why?
|
| Reproducibility of Results | 6 | 2015 | 20080 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2828 | 0.060 |
Why?
|
| Magnetics | 1 | 2006 | 600 | 0.050 |
Why?
|
| Phosphofructokinase-2 | 1 | 2022 | 32 | 0.050 |
Why?
|
| Lactate Dehydrogenases | 1 | 2022 | 27 | 0.050 |
Why?
|
| Hexokinase | 1 | 2022 | 125 | 0.050 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.050 |
Why?
|
| Radiology | 1 | 2015 | 2102 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2022 | 292 | 0.050 |
Why?
|
| Equipment Design | 3 | 2022 | 3520 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 260 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 2733 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5251 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2016 | 4642 | 0.040 |
Why?
|
| Respiration | 1 | 2006 | 1654 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2009 | 3562 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2014 | 1690 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2022 | 10446 | 0.030 |
Why?
|
| Heart | 2 | 2006 | 4393 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 1993 | 0.030 |
Why?
|
| Information Storage and Retrieval | 3 | 2006 | 822 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4563 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2014 | 68 | 0.030 |
Why?
|
| Device Approval | 1 | 2015 | 165 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2448 | 0.030 |
Why?
|
| Equipment Failure Analysis | 2 | 2006 | 848 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 389 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2022 | 2418 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 600 | 0.030 |
Why?
|
| Cytosol | 1 | 2016 | 887 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2016 | 652 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22072 | 0.020 |
Why?
|
| Risk Management | 1 | 2015 | 558 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2016 | 1167 | 0.020 |
Why?
|
| Liver | 2 | 2021 | 7509 | 0.020 |
Why?
|
| Electricity | 1 | 2010 | 182 | 0.020 |
Why?
|
| Occupational Health | 1 | 2015 | 805 | 0.020 |
Why?
|
| Humans | 14 | 2022 | 760621 | 0.020 |
Why?
|
| Female | 4 | 2021 | 391270 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 1273 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1728 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 1628 | 0.020 |
Why?
|
| Radio Waves | 1 | 2009 | 250 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 6216 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 1161 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 626 | 0.020 |
Why?
|
| Computing Methodologies | 1 | 2005 | 17 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5643 | 0.020 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2005 | 119 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3602 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1895 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2005 | 439 | 0.010 |
Why?
|
| Coronary Vessels | 2 | 2006 | 3112 | 0.010 |
Why?
|
| Cell Survival | 1 | 2014 | 5797 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2016 | 3663 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2011 | 2913 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1736 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 2138 | 0.010 |
Why?
|
| Calibration | 1 | 2005 | 816 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2846 | 0.010 |
Why?
|
| Insulin | 1 | 2016 | 6597 | 0.010 |
Why?
|
| Mitochondria | 1 | 2014 | 3600 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9185 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7475 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 9276 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22023 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13502 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18137 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54303 | 0.010 |
Why?
|
| Brain | 1 | 2022 | 26951 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 9501 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5201 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29749 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13630 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23376 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2005 | 2557 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 58741 | 0.010 |
Why?
|
| Male | 2 | 2016 | 359744 | 0.000 |
Why?
|
| Adult | 2 | 2016 | 219994 | 0.000 |
Why?
|
| Time Factors | 1 | 2005 | 40165 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_